Overview
Translating Immune Science Into Actionable Health Insights
At ImmunitasBio, we are driven by a shared passion: turning complex immune science into actionable insights for human health. As your dedicated partners in translational immunology and preclinical drug discovery, our team brings deep, hands-on expertise in immuno-oncology, cell & gene therapy, inflammation, allergy, and autoimmunity. Together, we empower the development of life-changing small molecules, vaccines, biologics, diagnostics, and consumer health products.
Our Journey – Born from a Global Health Challenge
ImmunitasBio was established during the COVID-19 pandemic, a defining moment that highlighted the critical importance of immunological science, biological testing, and vaccine research. Recognizing the urgent need for dependable scientific data and immune response analysis, we emerged with a clear purpose: to support researchers, healthcare organizations, and innovators during one of the most challenging public health crises in recent history.
As a trusted partner in scientific research, our early efforts focused on providing COVID-19 vaccine testing support, immune profiling, and data-driven insights that enabled researchers and healthcare stakeholders to make informed decisions in protecting public health.

Vision
To be a global leader in translational immunology, advancing innovative research, diagnostics, and therapeutics to transform human health.

Mission
To accelerate the journey from scientific discovery to clinical impact by delivering integrated translational research, bespoke analytical solutions for the global life sciences industry.
Supporting Innovation Across Multiple Industries
ImmunitasBio provides specialized research and development support across diverse sectors, including:
Integrity
- Trust built on scientific integrity
Quality
- Excellence in every experiment, every result
Expertise
- Deep Science, Meaningful insights
Flexibility
- Agile solutions for evolving challenges
Collaboration
- Partnerships that accelerate innovation








